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HIS article is not intended as a comprehensive nor a critical review
of the relationship of the Rh factor to hemolytic disease of the
newborn, but rather as an introduction to the paper on the "Moral ity of the Rh factor" to be given by Father Schwitalla. In this paper
. I will discuss the development of the work which has been done on the
Rh factor of the blood in humans, discuss briefly its relationship in
hemolytic disease of the newborn and indicate the value of Rh studies
particularly in relationship to pregnancy.

T

In their experiments during and just prior to 1937, Landsteiner lind
Wiener produced an antibody in rabbits by the injection of monkey
blood as an antigen. This new antibody not. only agglutinated the red
blood cells of monkeys but in addition agglutinated those of cert.ain white
humans. This indicated a new factOl" present in the red cells of certaill
humans Hnd because it had been developed by the usc of the blood of the
macacus rhesus monkey the name Rh was given it to indicate the original
source of the antigen. Further st.udies indicated that approximately
85% of whit.e humans possessed this Rh agglutinogen in their red cells
and in the other 15% it was absent. They were accordingly designated
as Rh posit.ive (containing the Rh agglutinogen) and Rh negative
(an absence of the Rh agglutinogen). This newly described factor
was not initially considered to be of great importance until in 1939
\iViener and Peters found the antibody to this newly discovered Rh factor
in three patients who had severe hemolytic reactions following transfusions of otherwise compatible blood. These patients apparently had
been immunized or better, iso-immunized, to the rhesus or Rh factor.
Levine and his coworkers then noted the very frequent occurrence of
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transfusion reactions in women who had stillbirths or infa nt.s with erythrohlastosis fetalis . At. this time L evine postulate(f the vC'r), interesting
th eory t.hat. an Rh n egat.ive moth er who bea rs an Rh positive rictus
beeallle sensitized in some manner to the Rh factor of t.he fetus and
suhsequently developed antibodies in her bloo(f to the Rh factor. These
Hntibodies in turn passed through t.he placenta a nd into the fetal blood
circ ul ation with r esulting agglutin a tion and hemol ys is of the fetal blood .
The intra-uterin e hemolysis in the infant then would account for th('
sevC're symptoms whi ch were found to be present in erythroblast.osis
retali s. B ecause ery throhlastosi s fetali s in its varied form s was demon st.rated to be the r esult of fetal and neo-natal hemolysis it. is rcfelTC'd to
I·oelay as helllolyt.ic diseasC' of infants and n ewborns .
The ant.ibody produeed by t.ht, artificial ill1ll1uniuttion of rabbits to
Ilion key hlooel h as certain eharHcterist.ics which arc identical with that
of the antibody produeed in wOI1lC'n d elivC' ring infants wit.h helllolytic
. disease. ThC' antihody pl'OducC'(f in hum a n s has been des igna t ed ~lnti
Ith o a nel tht' erythl'Ocytes which arc agglutinated h y this antibo(fy a n '
(lesignated as the Rho type. L ate r it. was found that there were two an(f
perhaps llIore f acto r s present. in human iso-immunir.at ion which wer C' not
p)"('sC'nt in th e original immunizatio n of rabbit s with 11l0nkey blood .
The two a(fditional ant.ibodies which have been detected in human s
arc givC'n the designations anti Rhl anel anti Rhll a nd accordingly,
thesC' sC'm detect. the presence or absence of the cOl'l'esponding three
H.h fador'" in hUlllan hlood , namely, Hh" Rhl and Rh ll . By the usc
of tlwse tin·C'e agglutinating sera we can thus differentiat.e eight. RII
l.ypC's in the first. four of whieh the Rh " fador is ahsf'nt amI in t.he
last. foul' is present, as follows:
('Iinie ally Rh negativt'
Ith n egative, Hh' , Hhl ' , Rhl Rh"
( ~ Iinic ally

Rh po sitivI'

1{llo' Hit, (Rh "lI), Rh~ (Rholl), Rh, RIt~
in this sehenl(' tlw Hh, and Rh~ f a ctors are considered to be cOlllbilIations of the HII" and Rhll allel Rho l'C'spect.ivcly as Hit ,,' and llh,,]] .
SillcC' t.he Hh" factor which cOlTesponos to th e original anti-rhesus
S('rUII I is by fal' the most alltigenic and therefore the lIIost illlport.ant
clinically, it is the vresence 01' absence of this factor which is deterlIIin ed by I1IOSt. of the antiserullI on the cOl1lmercial lIIarket. For
clinical p urposes we lIlay consider a ny blood in which t hr Rh " factor
is preSt'nt. t.o be Rh positive an(f t.hose in which tilt' Rh" facto!· is
absent. to \)(' Rh nega tive. This is true in approxilllately H,I) % of
individuals whil e t.he rHl'r r Hh Factors account for only approxi lIIately 2% of the white pop ul ation.
The presence 01' the absence of the Hh factor in the ~rythrocytes
IS her editaril y drtermin e(f Ilnd the Rh fac tor is t.rnnsmitteo to
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offsllring as a Mendclian dominant by a llair of allelic gelles, Hh
(dominant) and rh (rcccssive). Sincc cvcry individual posscsscs
a pail' of genes from cvery allelic scries of gcncs onc from the
father and onc frOIll t.he mothcr, thcrc arc thus thrce gPllot.ypes
possible.
Rit .FA C TOR 'rltANsMISSIOI\
TYPES

GENOTYPES

RhRh+
Rh+

rh rh
Rh Rh
Rh rh

Homozygous
Homozygous
Heterozygous

.l<'ronl this we can sec that fur the entire groull ot' eight Hh tYllcs,
there are twcnty-onc llossiblc gcnatypes. Since thc typc of blood
is determined by thc charactcr of thc blood of the parcnt and tl
gene inherited froUl each of tltc father and the l1Iothcl', the Hit
factor is inherited as in tlte following chart.
INHJo: H,l'l' A I\ C]'; 0]0' THJo:

PARENT

Hit

FA C TOH

P AR ENT

CHILl)

TYPE GENOTYPE

TYPE GENOTYPE

TYPE

RhRh+ Rh+
Rh+
Rh+

Rh-RhRhRh+
Rh+

Rh- (100%)
Rh+ (100%)
Rh+ ( 50%)
Rh+ (100%)
Rh+ ( 25%)
Rh + ( 50%)
Rh- ( 25%)

rh rh
Rh Rh
Rh rh
Rh Rh
Rh rh

rh rh
rh rh
rh rh
Rh Rh
Rh rh

GENOTYPE

rh rh
Rh rh
Rh rh
Rh Rh
Rh Rh
Rh rh
rh rh

Levine has desc ribed allother factor which because uf its reciprucal
relationship to thc Hh factor has been dcsnibed as the Hr factor.
Because of its pcculial' reciprucal relationship to the Hh factOl',
thc Hr factor by its llresence ur abscncc ill thc cryt.hrucytes has
been used to distinguish homozygous and heterozygous Rh positive blood. In this tcst cr,),throcytes frum humozyguus ilillividuais
are not agglutinated by the anti HI' serum.
Hecently it has becn found that the Rh factor as un antigl'1l llIay
produce more than onc tYlle uf antibudy. This secund type of anti body pruduced is sometillles designated as a blocking antibudy
which specifically unites with and coats the surface uf the Rh pusitive erythrocytes without illducing physical effective aggiutillatiull.
In other words the antibody is incomlliete becausc unly the first
stage of the r eaction occurs. The specifically coated Rh positive
erythrocytes are now ineapablc of reacting wIth the usual anti Rh
agglutin and as a result special tests havc been described by means
of whi.ch it is possible to detect the anti Rh agglutin in the usual
manner and the so-callcd blocking antibody as well. The blocking
antibody according to Wiencr, is of more importance in the producti.on of hemolytic disease than thc Rh antibody. The blocking
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antibody has a smaller molecule and theoretically passes the
placental barrier more readily, and it is strongly antigenic.
Many examples of iso-immunization by repeated transfusions of Rh
positive blood into Rh negative recipients are recorded in the literature.
Levine has found a definite history of prior transfusions in sixteen of a
series of twenty-five cases of hemolytic disease of the newborn in the first
born of Rh negative women. Levine has further emphasized the importance of small immunizing doses of blood and has calculated that only
.13.cc. of fetal blood is required to immunize the Rh negative mother.
As a result of these alld other observations we must assume that once
an individual is immunized to the Rh factor, either by repeated transfusions, intramuscular injection of blood or by pregnancy, he must
be considered as immunized for the remainder of his natural life, and
further that with each succeeding exposure to Rh positive blood he
will probably produce increasingly greater quantities of antibody. Accordingly, it is important in pediatric practice to administer only Rh negative
blood to Rh negative female infants and to minimize the intramuscular
injection of blood from any donor who is Rh positive. One or more transfusions of Rh positive blood administered to an Rh negative female infant
rn ay prevent her many years later from having on e or more normal Rh
positive infants. Further, Rh testing is particularly indicated if repeated
transfusions are anticipated especially in young females before and during
t,he childbearing period, and in some, past the menopause, if they have
borne children, particularly if there is any evidence in the history which
would indicate previous immunization to the Rh factor. Humans, as well
as experimental animals, differ considerably in the ease with which they
become sensitized to various antigens. In humans this is indicated by
the fact that approxim ately one out of t en marriages are of the serologic
sequence (Rh positive male, Rh negative female) which is capable of
producing infants with hemolytic disease. Actually only one in approximately two-hundred fifty newborns is so affected. Further, sensitization
in pregnancy probably increases only with repeated exposures to the Rh
factor as an antigen and as a consequence hemolytic disease in the first
borne is relatively uncommon unless there is a history of previous exposure to the Rh factor. As a rule we can anticipate one, two, or perhaps
more perfectly normal children who may be Rh positive even though
the subsequent children are so affected. Hemolytic disease of the newborn
is gradually increasing in importance because of two essential factors:
first, the diagnosis is made more readily than formerly because of increased diagnostic acumen and additional criteria upon which a diagnosis
can be based; and secondly, the lowering mortality in hemolytic disease
because of improved methods in treatment such as prompt transfusion.
The diagnosis of hemolytic disease of the newborn usually does not
present much difficulty. However, there are a number of diseases which
must be kept in mind and in the differential diagnosis we must consider
congenital syphilis, in tra-uterine or post-partum infections of the infant,
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ccrtain hcnlUrrhagic disease of the ncwborn, very rarely congenital mal formation of the bilc ducts and p hy siologi c icte rus whi ch very frequently
occurs in ll cw born babies.
If we recall t hat there arc variou s clinical types of hemoly t ic
di sease of the newborn, we a re in a l1Iuch better position to make t he
proper clinical diagnosis. These forms of hemolytic disease include
fetal hydrops which is t he most severe and has a mortality rate of
approxim ately 100%, t he j a undiced form, a nd the jaundiced forl1l
anemia a nd fin ally, t he form which is manifest simply as a hemorrhagic diathesis. These yarious form s a re apparently related
genetically and etiologically .
The evidences of hemolytic disease in the infa nt may be found in the
Illother or in the infa nt. In t he parents we would expect the serologic
sequence of an Rh positive father a nd a n Rh negative mother. If the
lIIother becomes immunized to the blood of t he fetus, there will be nil
antibodies in her blood SeHlIl1. In somc there may possibly be a hi story
of p revious transfusions especiaJly with Rh positive blood or the intranlu sc ula r inj ection of blood during infancy. During pregnancy t her e may
be evidences of hydra mnios, death of the fetus and at birth there is frequen t ly yello,w a mniotic fluid and enla r gemen t of the placenta. The
presence of Hh antibodies in t he mo t her's blood ca n be possibly used in
a limited way to predict. t he OCCUlTence of hemolytic di sease in the
infa nt . If no antibody is found or if small a mounts a r e found r egula rly
the infants will usually have no evidence of hemolytic disease. If large
amounts of antibody or small amo unts of a ntibody a re r epeatedly found,
the infants may develop some form of hemolytic disease.
Early appearance of large a mounts of a ntibody gcncrally indicates
a serious prognosis for the infant. If these observations are repeat edly
confirmed, it will allow us to predict in advance the form and approximate severity of the hemolytic p rocess a nd as a consequence in stitute
treatment of the infant at a n earlier date. In t he infa nt, at birth, or
developing soon after birth, we find a jaundice, edema, hepatomegaly a nd
splenomegaly with a normoblastic p icture in the blood and bon e III a ITOW
smears.
These evidences vary considerably with the different forms of thc
disease mentioned above. At necropsy examinat ion we find evidences
of a hyperplastic normoblastic bone marrow with foci of extra-medul lary hematopoiesis in the liver, spleen, a nd kidneys. Oftentimes in
the lungs we find helllocytoblasts in the pulmonary capilla ries. III
some of the lJlore severely a ffect ed infants there is evidence of keru icterus and usually evidences of enla rgement of the liver aJl(I of the
spleen.
In hemolytic disease immediate transfusion with adequate uruountti
of Rh nega tive blood is, at present, the treatment of choice. If Rh negative blood is used there is no hemolysis of the t ran sfu sed blood by the
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antibody in the infant. The infant is not breast fed because of the possibility of continued transfer of the Rh antibody from mother to infant
in the breast milk. For the most part repeated small transfusions have
been u sed quite successfully; however, " Tiener has recommended massive
replacement transfusions in which the infant is bled of his blood through
an artery and at the same time blood from a n Rh negative don or is
given intravenously. The results of treatment by small tra nsfusioll s in
our most recent 18 cases of hemolytic disease may be seen ill the folio\\"illg chart:
HEMO I,YTIC DISEASE OF THE N :F:WJIOltN

(Summary of R ecen t Cases)
No.
D eaths
Cases
Icteric
16
2
Hydrops
1
o
Adm. from a nother ho sp ital 1
1
Total
.
18
3
This is obviously a much lower 1lI0rtality rate t han we lIligltt a n ticivate without the benefit of immedi ate and adequate trallsfusions. III
16 of these 18 cases the transfusion data a r e sUlllm arized Oil the accolllpanying chart :
INTRA-OSSEO US TltANsFUSION DATA

(16 cases)
Trallsfusions
56
No. per case (Aver. )
3.25
188.5
Cc.per case (Aver.)
We have used the intra-osseous as well as the umbilical route ill
our patients for convenience and ease of transfusion. For illfants ill
whom hemolytic disease was anticipated we have been able to use the
umbilical cord very successfully. \i\Tit h all of these facts in llIind I would
like to suggest the following policy ill pregllant wOlllen with r egard to
the Rh f actor.
SUGGESTED POLICY I N PREGNAN CY

1. All obstetric patients a r e Hh typed at the tillle of first visit.
In the Rh negative group also type husballd , other childrell,
and if possible the parents of husballd. Do Hr typillg on
husband if available.
~. In all Rh negative fem ales with Rh positive husbands do antiRH and blocking tests at 2 week in te rvals begiuning at 24th
week of gestation and at 1 week in tervals after 30 weeks
gestation.
3 . Have Rh negative blood available for immed iate transfusioll
of all infants delivered of wOlllen wit h anti Rh or blocking
antibodies.
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4. In all WOlllell with Rh a ntibodi es study the infant car efully at
birth notillg the size and weight of placenta, presence of
hy(lramnios, wlor of amniotic fluid and repeated blood smears
Oil infant.
If these various suggestions arc follow ed it is entirely probable that
henlOlytic disease call be anticipated with some degree of certainty and
adequate therapeutic steps carried out. I mention two more items not
because they a re of clinical importance at this time but because they
Ill";'y be theoretically important at a later date. If an individual is simultaneously inj ected with two antigens he will react almost entirely to the
stronger of these two a ntigens. As a consequence it is theoretically possible to give during ea rly pregnancy, a strong antigen and inhibit sensitization to the Rh factor. At present we are unable to predict which
women are susceptible to Rh sens itization.

The seco nd observation is based on the wOl·k of Homberger who has
found in experimental animals immunized with rhesus cells that the
sillluitaneous administration of sodium salicylate will inhibit the production of antibodies. It is impossible to use this drug at present because
of the high toxicity of the drug but the observation is of illlPortance
bec ause it is entirely possible that other chemical agents rnay be found
which will inhibit the production of the Rh antibodies but will not have
the high toxicity of large doses of sodium salicylate.
S U MMARY;

I have reviewed the rece nt literatu re concerning the Rh factor allti
its relationship to hemolytic disease of the newborn. As we study this
problem more thoroughly we become impressed particularly with potential
sensitization of young fem ales by indiscriminate use of blood. It is
probable that we should omit the use of intra-muscular blood, and Rh
positive blood to Rh negative young female infants. 'Vhen patients come
to us worried because of incomplete information based on popular
accounts of this subject in lay magazines we can assure them that not
all women become sensitized equally and hence there is a strong probability that they will never deliver an infant with hemolytic disease even
though the serologic sequence is consistent. Further, that if they should
develop this form of sensitivity they will probably have several normal
children before they have one with hemolytic disease, and if the
father is heterozygous Rh positive 50 % of the children will be born as
Hit negative infants and hence free of hemolytic disease. If the infants
are born with hemolytic disease and especially if this is anticipated,
immediate prompt treatment improves the prognosis immeasurably and
will result in normal living children even though they have hemolytic
disease in infancy. Further work can be done along the line suggested
by double immunization and the use of chemical reagents to diminish
the capability of forming antibodies.
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